Lamisil 125mg. 250mg Tablet
PDF Leaflet Revision Date: 05 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of fungal infections of the skin and onychomycosis.
Dosage (summary)
Adults: 250 mg once daily; duration varies by infection type.
Special Populations
- Liver impairment
- Renal impairment
Pregnancy & Breastfeeding
Use during pregnancy if necessary; contraindicated in breastfeeding.
Key Drug Interactions
- CYP2D6 inhibitors
- Cimetidine
- Fluconazole
Contraindications
- Hypersensitivity to terbinafine
- Impaired liver function
- Breastfeeding
Common side effects
- Headache
- Gastrointestinal symptoms
- Skin reactions
Counselling Points
- Take with water at the same time daily
- Report liver symptoms
- Avoid breastfeeding while on treatment
Serious warnings
- Hepatotoxicity
- Serious skin reactions
- Blood dyscrasias
Important Disclaimer
The Lamisil 125mg. 250mg Tablet professional information leaflet below is the property of Novartis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
